Search Within

Nancy T Sklarin

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
Groups
  1. Breast Medicine Service (23)
  2. Department of Medicine (23)
  3. Epidemiology and Biostatistics (23)
  4. Solid Tumor Oncology Division (23)
  5. Survivorship Research (22)
  6. Biostatistics Service (19)

More Groups

People
  1. Clifford Hudis (20)
  2. Monica Fornier (17)
  3. Andrew Seidman (14)
  4. Gabriella D'Andrea-Carlino (14)
  5. Larry Norton (14)
  6. Teresa Gilewski (13)

More People

Years
  1. 2021 (1)
  2. 2018 (1)
  3. 2016 (1)
  4. 2015 (2)
  5. 2013 (1)
  6. 2012 (4)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Breast Cancer Research and Treatment (3)
  3. Cancer Research (3)
  4. Clinical Cancer Research (3)
  5. Clinical Breast Cancer (2)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (6)
  3. Springer (3)
  4. Elsevier Inc. (2)
  5. Informa Healthcare (1)
  6. Wiley Blackwell (1)

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
    Journal Article

    Belum, V. R.; Silva, G. D.; Laloni, M. T.; Ciccolini, K.; Goldfarb, S. B.; Norton, L.; Sklarin, N. T.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer
    Journal Article

    Murphy, C. G.; Mallam, D.; Stein, S.; Patil, S.; Howard, J.; Sklarin, N.; Hudis, C. A.; Gemignani, M. L.; Seidman, A. D.
    Cancer (2012)

    Fulltext@MSK | Save